ABT-199 cas:1257044-40-8
ABT-199
| Catalog # | Pkg Size | Price(USD) | Quantity | Buy this product |
|---|---|---|---|---|
| R-C-594 | 200mg | 225.00 | + Add to cart |
|
| R-C-594 | 500mg | 405.00 | + Add to cart |
|
| R-C-594 | 1g | 740.00 | + Add to cart |
|
|
|
||||
Product description
Venetoclax (ABT-199,GDC-0199)is a Bcl-2-selective inhibitor with Ki of <0.01 nM in cell-free assays,4800-fold more selective versus Bcl-xL and Bcl-w,and no activity to Mcl-1.Venetoclax is reported to induce cell growth suppression,apoptosis,cell cycle arrest,and autophagy in triple negative breast cancer MDA-MB-231 cells.
| Appearance | N/A |
|---|---|
| Molecular Weight | N/A |
| Purity | >95% |
| PDI by GPC | <1.5 |
| Solubility | DMSO |
| Storage | -20℃, protected from light and moisture |
| Transportation | 4-25℃ temperature for up to 2 weeks |
| Stability | 1 year |
Document
Related Product

Items-$0.00

Email:
Tel.:
msds---ABT-199
RuixiBiotechCo.Ltd /KamulinBiotechco.ltd
Add: Room 20F 2002, Meiyuan Building, Yanta District, Xi’ an City, Shaanxi Province 710061 China
Tel: 02988811435
Fax: (86-29)8881-1435
Email: sales@ruixibiotech.com
Web: http://www.ruixibiotech.com


